1. Home
  2. SCNI vs FAMI Comparison

SCNI vs FAMI Comparison

Compare SCNI & FAMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCNI
  • FAMI
  • Stock Information
  • Founded
  • SCNI 2003
  • FAMI 2015
  • Country
  • SCNI Israel
  • FAMI China
  • Employees
  • SCNI N/A
  • FAMI N/A
  • Industry
  • SCNI Biotechnology: Biological Products (No Diagnostic Substances)
  • FAMI Packaged Foods
  • Sector
  • SCNI Health Care
  • FAMI Consumer Staples
  • Exchange
  • SCNI Nasdaq
  • FAMI Nasdaq
  • Market Cap
  • SCNI 2.0M
  • FAMI 2.1M
  • IPO Year
  • SCNI N/A
  • FAMI 2018
  • Fundamental
  • Price
  • SCNI $1.52
  • FAMI $1.60
  • Analyst Decision
  • SCNI
  • FAMI
  • Analyst Count
  • SCNI 0
  • FAMI 0
  • Target Price
  • SCNI N/A
  • FAMI N/A
  • AVG Volume (30 Days)
  • SCNI 3.0M
  • FAMI 50.6K
  • Earning Date
  • SCNI 08-19-2025
  • FAMI 08-19-2025
  • Dividend Yield
  • SCNI N/A
  • FAMI N/A
  • EPS Growth
  • SCNI N/A
  • FAMI N/A
  • EPS
  • SCNI N/A
  • FAMI N/A
  • Revenue
  • SCNI $658,000.00
  • FAMI $43,831,754.00
  • Revenue This Year
  • SCNI N/A
  • FAMI N/A
  • Revenue Next Year
  • SCNI N/A
  • FAMI N/A
  • P/E Ratio
  • SCNI N/A
  • FAMI N/A
  • Revenue Growth
  • SCNI N/A
  • FAMI N/A
  • 52 Week Low
  • SCNI $1.40
  • FAMI $1.43
  • 52 Week High
  • SCNI $6.18
  • FAMI $7.07
  • Technical
  • Relative Strength Index (RSI)
  • SCNI 29.96
  • FAMI 38.89
  • Support Level
  • SCNI $1.40
  • FAMI $1.51
  • Resistance Level
  • SCNI $1.64
  • FAMI $2.10
  • Average True Range (ATR)
  • SCNI 0.24
  • FAMI 0.17
  • MACD
  • SCNI -0.03
  • FAMI -0.03
  • Stochastic Oscillator
  • SCNI 5.77
  • FAMI 14.75

About SCNI Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH antibodies (NanoAbs) targeting diseases with large unmet medical needs, and the other a boutique CDMO providing services to help biotech companies efficiently bring their products to market by leveraging Scinai's drug development and GMP and non-GMP manufacturing capabilities for pre-clinical and clinical studies. The company generates maximum revenue from the provision of CDMO (Contract Development and Manufacturing Organization) services.

About FAMI Farmmi Inc.

Farmmi Inc is an investment holding company. Through its subsidiaries, it acts as a supplier of agricultural products. It is an agricultural technology enterprise focused on its supply chain platform by promoting edible mushroom products and agriculture technology. Its product offerings include tapioca, corn, red dates, shiitake mushrooms, mu er fungus, other edible fungi, and other agricultural products. Geographically, the company's products are sold in China, Southeast Asia, Japan, North America, Europe, and the Middle East under the Forasen and Farmmi brands.

Share on Social Networks: